Ibyerekeye twe
Soma IbikurikiraGOInnovita Biological Technology Co., Ltd. (hamwe n’ibigo biyishamikiyeho, hamwe bizwi ku izina rya “INNOVITA”,) ni isosiyete ikora ibijyanye n’ibinyabuzima yibanda ku bushakashatsi, iterambere, umusaruro no kugurisha ibicuruzwa bya vitro bipima POCT.Igizwe naInnovita (Beijing) , Innovita (Tangshan)naInnovita (Guangzhou).
Yashinzwe mu 2006
● 69 NMPA Impamyabumenyi zabonetse, harimo 53 zo mu cyiciro cya III
● 2020.02.22, Innovita yari imwe mu masosiyete ya mbere mu Bushinwa yabonye NMPA yemewe na COVID-19 Icyemezo cya Antibody.
Ibicuruzwa byacu
turatanga inama yo guhitamo
Innovita
- Imbaraga zacu
- Imbaraga zacu R&D
- Icyemezo Cyiza
INNOVITA nisosiyete ikora ibishoboka byose kugirango isuzume ibisubizo byubuvuzi, iharanira uburyo bwiza bwo kwivuza bugamije kuzamura ubuzima n’imibereho myiza yabantu kwisi yose.
INNOVITA yubatsemo uburyo butandatu bwa tekiniki nka antigen & antibody itegura, umuco wa virusi, zahabu ya colloidal, ELISA, chromatografiya ya fluorescence, immunofluorescence, kandi ikora gahunda yigihugu y’ubushinwa R&D mu rwego rw’ubushakashatsi bw’indwara zikomeye zanduza ndetse n’indi mishinga myinshi y’ubuzima rusange. .
INNOVITA yubahiriza ubuziranenge bwa GMP kandi ifite ibyumba 100.000 byogusukura kugirango umutekano hamwe nisuku byibicuruzwa byacu.
Dushyira mu bikorwa byimazeyo sisitemu yo gucunga neza ISO 13485 kandi tugakurikiza ibipimo ngenderwaho bya EU, FDA, nibindi, kugirango ibicuruzwa byose byujuje ibyifuzo byabakiriya bacu kwisi yose.
tuzakwemeza ko uzahora ubona
ibisubizo byiza
-
SHAKA 2006 -
ABAKOZI 400+ -
IBIHUGU / AKARERE 70+ -
AMASHAMI 3
Ibyiciro byibicuruzwa
Kubaza pricelist
tanga nonahaibishyaamakuru
reba byinshi-
Covid-19 Ag Ikizamini Yabonye TGA
Ku ya 27 Mata 2022, Innovita 2019-nCoV Ag Ikizamini cyabonye TGA.Inomero yicyemezo: DV-2021-MC-25164-1 Kugeza ubu, Innovita covid-19 antigen ikizamini cyo gukoresha umwuga no kwipimisha ufite ob ... -
INNOVITA na DAB Umuhango wo gutanga
-
Covid-19 Ag Ikizamini Yabonye NMPA
Ku ya 29 Werurwe 2022 Test Innovita 2019-nCoV Ag Ikizamini (Latex Chromatography Assay) cyemejwe na NMPA.
